Dec 22 (Reuters) - Prima BioMed Ltd PRR.AX :
* Initiates phase iib study in metastatic breast cancer
* Says first patient expected to be dosed in early 2016
* Source text for Eikon ID:nMKWdLyq1a
* Further company coverage PRR.AX
Dec 22 (Reuters) - Prima BioMed Ltd PRR.AX :
* Initiates phase iib study in metastatic breast cancer
* Says first patient expected to be dosed in early 2016
* Source text for Eikon ID:nMKWdLyq1a
* Further company coverage PRR.AX